Juan Tong

13PUBLICATIONS
7CO-AUTHORS
Haematological tumoursGene and molecular therapyAutoimmunityRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 11, 2026
Superior Efficacy and Deep Molecular Remission with Venetoclax Plus Hypomethylating Agent in Elderly Acute Myeloid Leukemia: A Real-World Comparative Cohort Study.

|Apr 30, 2026
Venetoclax Plus Hypomethylating Agents for Treatment-Naïve Myelodysplastic Syndromes with Increased Blasts: A Prospective Multicenter Cohort Study.

|Mar 23, 2026
Development and Validation of a Novel Thrombosis Prediction Model for Adult Immune Thrombocytopenia (ITP-THROMBO).

Huiling Yan, Xing Hu, Lijun Zhu

|Mar 31, 2025
Real-World Analysis of Clinical Characteristics, Treatment Outcomes, and the Novel Predictive Model for Patients with Thrombotic Thrombocytopenic Purpura (TTP) and TTP-Like Syndrome.

Mengya Lv, Xing Hu, Lijun Zhu

|Aug 05, 2024
Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF.

Dan Liu, Juan Tong, Erling Chen

|May 13, 2024
Can COVID-19 Increase Platelet in Adult Immune Thrombocytopenia During the TPO-RA Administration? A Real-World Observational Study.

Xiaoyu Wang, Yingqiao Zhu, Dan Liu

Pageof 3

Frequent Collaborators

8 joint publications

Changcheng Zheng

2 joint publications

Li Zhou

1 joint publications

Guifang Li

1 joint publications

Zimin Sun